Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583414 · ClinicalTrials.gov registry record · NA
Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients
A NA study of Abdominal Aortic Aneurysm and Iliac Aneurysm, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 401
- Enrollment target
- 1
- Study location
NCT00583414: Completed NA study of Abdominal Aortic Aneurysm and Iliac Aneurysm, sponsored by The Cleveland Clinic.
NCT00583414 is a NA study of Abdominal Aortic Aneurysm and Iliac Aneurysm that has completed, run by The Cleveland Clinic. The registered enrollment target is 401 participants, roughly in line with the 429-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00583414, a NA study of Abdominal Aortic Aneurysm and Iliac Aneurysm, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 401 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the role of abdominal aneurysm and iliac aneurysm exclusion using an endovascular prosthesis.
Primary Outcome
Absence of blood extravasation outside of aneurysm sac demonstrated by CT scan
Conditions Studied
Interventions
- DEVICE Endovascular Aneurysm Repair
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 1998-09 |
| Est. Completion | 2017-10 |
| Phase | NA |
What the finished NCT00583414 record still lists
NCT00583414 is an interventional study that assigns participants to a tested intervention. The registered 401 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 429-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target.
The record links to 3 conditions, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Endovascular Aneurysm Repair is the first listed.
NCT00583414 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00583414 about?
NCT00583414 is a clinical study titled "Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients". The purpose of this study is to assess the role of abdominal aneurysm and iliac aneurysm exclusion using an endovascular prosthesis.
What is the current status of trial NCT00583414?
This trial is currently completed. It is a NA study. The enrollment target is 401 participants. The study started on 1998-09. Estimated completion is 2017-10.
What conditions does trial NCT00583414 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm, Iliac Aneurysm, Internal Iliac Aneurysm.
What interventions are being tested in trial NCT00583414?
The interventions under investigation include: Endovascular Aneurysm Repair (DEVICE).
Who is sponsoring clinical trial NCT00583414?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00583414 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00583414's enrollment target sits among peer trials
401 5th of 16 higher than 12 of 16 other Abdominal Aortic Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Abdominal Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
RECRUITING · NA
-
Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques
RECRUITING · NA
-
Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)
RECRUITING · NA
-
3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair
ACTIVE NOT RECRUITING · NA
-
Post-Approval Study of the TREO Abdominal Stent-Graft System
ACTIVE NOT RECRUITING · NA
-
Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia